The new data further cemented the therapy’s consistent safety profile from previous studies as well as demonstrated a newfound durability in patients with later-onset spinal muscular atrophy.
from Front page feed https://ift.tt/3dhFyoA
from Front page feed https://ift.tt/3dhFyoA
Comments
Post a Comment